MAP1LC3A and squamous cell carcinoma: Furthermore, high LC3 immunoreactivity was 41.5% (34/82) in the hypopharyngeal squamous cell carcinoma specimens as compared with 74.1% (40/54) in adjacent non-cancerous tissues (P=0.0002) (Figure 1C and 1D).